Overview

Treatment of Incontinence Without Memory Problems

Status:
Completed

Trial end date:
2018-07-01

Target enrollment:

Participant gender:

Summary

An 8-week randomized, controlled, pilot clinical trial of Mirabegron compared to a standard anticholinergic therapy (Detrol LA) in elderly women with urgency urinary incontinence.

Phase:

Phase 4

Details

Lead Sponsor:

University of California, San Francisco

Treatments:

Mirabegron
Tolterodine Tartrate